Finance of Fighting Cancer - Sario, Azhar ul Haque
43,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
22 °P sammeln
  • Broschiertes Buch

This book dives into the financial side of cancer treatment, focusing on immunotherapy. It analyzes costs of new treatments, comparing them to traditional methods.Chapter 1 gives an economic overview of cancer immunotherapy, including cost analyses, funding, and global impact. Chapter 2 explores checkpoint inhibitor pricing and financial aid models. Chapter 3 breaks down CAR T-cell therapy expenses, while Chapter 4 examines cancer vaccine development costs.Chapters 5-11 cover various immunotherapies, discussing development costs, market adoption, and financial policies. Chapter 12 proposes…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
This book dives into the financial side of cancer treatment, focusing on immunotherapy. It analyzes costs of new treatments, comparing them to traditional methods.Chapter 1 gives an economic overview of cancer immunotherapy, including cost analyses, funding, and global impact. Chapter 2 explores checkpoint inhibitor pricing and financial aid models. Chapter 3 breaks down CAR T-cell therapy expenses, while Chapter 4 examines cancer vaccine development costs.Chapters 5-11 cover various immunotherapies, discussing development costs, market adoption, and financial policies. Chapter 12 proposes strategies to lower costs and improve global access.Essential reading for healthcare financiers, policymakers, and those involved in cancer treatment, this book provides key insights into the financial implications of advanced cancer therapies.
Autorenporträt
Azhar ul Haque Sario é um autor de bestsellers e cientista de dados com um registo notável de realizações. Este ex-aluno de Cambridge traz uma riqueza de conhecimentos para o seu trabalho, possuindo um MBA, ACCA (nível de conhecimento - FTMS College Malaysia e London College of Accountancy, Londres), BBA e várias certificações Google.